From biosynthesis to function: the roles of ether lipids in cancer development and treatment. [PDF]
Hu Z +5 more
europepmc +1 more source
Lysophosphatidic Acid Regulates Trafficking of β2-Adrenergic Receptors [PDF]
Elena Shumay +3 more
openaire +1 more source
Lipoprotein(a) and the Vascular Redox Interface: Linking Arteriosclerosis, Thrombosis, and Vascular Biology. [PDF]
Zubiran R, Remaley AT.
europepmc +1 more source
Lysophosphatidic acid receptor 1 (LPAR1; EDG2; LPA1) [PDF]
openaire +1 more source
Developmental Changes in the Expression of Lysophosphatidic Acid Receptor 4 in the Mouse Brain.
Ishidou A, Ishiguro T, Nagata KI, Ito H.
europepmc +1 more source
Inhibition of autotaxin activity with IOA-289 decreases fibrosis in mouse E0771 breast tumors. [PDF]
Tang X +4 more
europepmc +1 more source
GPR35 is a novel lysophosphatidic acid receptor
GPR35 is a rhodopsin-like G protein-coupled receptor identified in 1998. It has been reported that kynurenic acid, a tryptophan metabolite, may act as an endogenous ligand for GPR35. However, the concentrations of kynurenic acid required to elicit the cellular responses are usually high, raising the possibility that another endogenous ligand may exist.
openaire
Oxypeucedanin attenuates neuropathic pain in male mice via inhibiting lysophosphatidic acid receptor signaling. [PDF]
Li J +11 more
europepmc +1 more source
LPAR6 Inhibits the Progression of Hepatocellular Carcinoma (HCC) by Suppressing the Nuclear Translocation of YAP/TAZ. [PDF]
Bao G, Zhai M, Yan Y, Wang Y, Damirin A.
europepmc +1 more source
Evaluation of Lysophosphatidic Acid Effects and Its Receptors During Bovine Embryo Development. [PDF]
Yu B +5 more
europepmc +1 more source

